Effect of Isoniazid Prophylaxis Therapy on the Prevention of Tuberculosis Incidence and Associated Factors Among HIV Infected Individuals in Northwest Ethiopia: Retrospective Cohort Study

BACKGROUND: Treating latent tuberculosis (TB) infection with Isoniazid (INH) among human immune virus (HIV) infected patients reduces active TB occurrence and death by 62% and 26%, respectively. Even though other studies show aforementioned evidence, TB incidence and its associated factors among HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Beshaw, Mulat Addis, Balcha, Shitaye Alemu, Lakew, Ayenew Molla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197569/
https://www.ncbi.nlm.nih.gov/pubmed/34135640
http://dx.doi.org/10.2147/HIV.S301355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197569/
https://www.ncbi.nlm.nih.gov/pubmed/34135640
http://dx.doi.org/10.2147/HIV.S301355

Ejemplares similares